Ready-made vs. Custom-made Carriere Motion Appliance

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-16
SponsorMansoura University

About this trial

The aim of this study is to evaluate the effect of custom-made CMA vs. the ready-made CMA.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients age (12-15) years.

Full permanent dentition.

Class II malocclusion with at least an end-on Class II molar relationship bilaterally.

Disqualifiers

Systemic conditions that may interfere with the treatment.

Bad habits that might jeopardize the appliance.

Transverse discrepancy.

Previous orthodontic treatment.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Custom-made Carriere motion appliance

    Device

    custom-made CMA from brackets, buccal tubes, stiff wire, and NiTi coil springs to treat class II malocclusion by molar distalization.

  • Ready-made Carriere motion appliance

    Device

    Ready-made Carriere motion appliance to treat class II malocclusion by molar distalization.

Treatment groups

24 Participants
are divided into 2 treatment groups
Group A: Custom-made CMAExperimental treatment 1 intervention
Group B: Ready-made CMAActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Treatment duration

in about 6 months from the start of treatment till reaching class I molar relation

Time frame
up to 6 months from the start of treatment until the date of first documented progression
2

Skeletal and dental changes

angular and linear cephalometric measurements

Time frame
up to 6 months from the start of treatment until the date of first documented progression

Secondary outcomes

1

Soft tissue changes

angular and linear cephalometric measurements

Time frame
up to 6 months from the start of treatment until the date of first documented progression
2

Patient satisfaction

patient questionnaire about oral health related quality of life: their satisfaction and discomfort

Time frame
up to 6 months from the start of treatment until the date of first documented progression

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.